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Abstract 
 
Objective: The objective of this selective EBM review is to determine whether or not the use of 
oral isotretinoin is more effective than oral antibiotics in the treatment of severe acne. 
Study Design: Review of all English language primary studies published after year 2000. 
Data Sources: Three randomized control trials all found using PubMed. 
Outcomes Measured: Total number and percentage change in total acne lesions from baseline at 
various intervals. 
Results: A randomized control trial (RCT) by Gollnick et al. (2001) found that oral isotretinoin 
was more effective than combination therapy involving minocycline in treating severe 
inflammatory acne, but that isotretinoin caused more negative side effects. In a RCT by Oprica et 
al. (2007), it was found that oral isotretinoin was more effective than tetracycline in treating acne 
vulgaris with prolonged significant remission.  A RCT by Tan et al. (2014) found that although 
doxycycline induced earlier reduction in total acne lesions, isotretinoin was still superior in 
reduction of acne lesions by week 20 of treatment. 
Conclusions: All three RCT’s included in this study indicate that oral isotretinoin is more 
effective than oral antibiotic therapies in the treatment of severe acne. 
Keywords: isotretinoin, acne, antibiotics. 
 
 
 
 
 
 
 
 
 
 
 
Thomas, Isotretinoin for Acne Treatment, 1 
 
 
Introduction 
 Acne vulgaris is a common dermatosis capable of producing significant psychological 
and physical scarring.  It is a disease of pilosebaceous follicles, involving follicular 
hyperkeratinization, increased sebum production, bacterial growth within the follicle, and 
inflammation.9 Therapy involving oral isotretinoin or oral antibiotics have long been mainstays 
of treatment of severe acne vulgaris, and this paper evaluates three randomized controlled trials 
comparing the overall effectiveness of each in acne treatment. 
Research in treatments of acne is important to healthcare providers because acne can 
cause significant psychological impairment to patients, affecting their work and social lives. 
Acne is also the most common skin condition in the United States, affecting up to 50 million 
Americans annually.2 The costs in the U.S. associated with the treatment of acne are greater than 
$3 billion.1 There is not an exact estimate of healthcare visits due to acne, but according to a 
2010 study, there were 39 million visits to dermatology offices alone, with acne being in the top 
four reasons for visits.11 
The sequence of events leading to acne lesions is not fully understood, but lesions are 
brought on by plugging of the sebaceous follicle, increased sebum production, proliferation of 
bacteria in the follicle, and then inflammation.4 An estimated 35-90% of adolescents experience 
some form of acne, which tends to resolve by the third decade of life, but may still persist into 
adulthood.9 Acne is a clinical diagnosis, and there is no universal classification system for the 
severity of acne, but lesion counting and descriptions of the lesions, such as comedones, papules, 
pustules and nodules usually help guide treatment.9  
Treatment of mild acne usually begins with applying topical products containing benzoyl 
peroxide.4 If that fails, second line treatment usually consists of prescription antibiotic cream, 
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gel, or lotion.4 These treatments are followed by prescription topical retinoids or azelaic acid.4 
Acne refractory to topical medications is then treated with oral antibiotics.4 Finally, if all 
treatments fail, oral isotretinoin can be prescribed, which is usually held for last line treatment 
due the potential for significant side effects associated with it.4  
Oral Isotretinoin and oral antibiotics are accepted treatment options for severe acne 
vulgaris, but isotretinoin is known to have more severe adverse effects than oral antibiotics, 
including severe birth defects and excessively dry skin.6 Even though both medications treat 
severe acne, it appears that effectiveness of isotretinoin is superior to antibiotics in reduction of 
total acne lesions, and therefore may be worth the risk of adverse effects for some patients with 
severe acne vulgaris refractory to prior treatments. 
Objective 
 The objective of this systematic review is to determine whether or not the use of oral 
isotretinoin is more effective than oral antibiotics in the treatment of severe acne. 
Methods 
 Three randomized controlled trials were included in this systematic review. The studies 
were selected based on populations studied, interventions used, comparisons made, and 
outcomes measured. The populations studied in all three RCT’s consisted of patients greater than 
12 years of age with moderate to severe facial acne. Gollnick et al.3 included males aged 15-31, 
whereas Oprica et al.5 included male and female patients aged 15-35, and Tan et al.8 included 
male and female patients aged 12-35.  
 For all studies included in this review, the intervention utilized was administration of oral 
isotretinoin. For Gollnick et al.3, participants received oral isotretinoin at a cumulative dose of 
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106-112 mg/kg for 6 months. Participants in the Oprica et al.5 study received oral isotretinoin at a 
dose of 1 mg/kg/day in two divided doses for 6 months, and participants in the Tan et al.8 study 
received oral isotretinoin at 1 mg/kg/day for 20 weeks.  
 Articles were researched via the PubMed database using key words such as isotretinoin, 
antibiotics, and severe acne, and were selected based on relevance to the clinical question and 
because outcomes included patient oriented evidence that matters (POEMs). All searches were 
set for English language and all articles searched were published in peer reviewed journals. 
Inclusion criteria for the purpose of this paper included randomized controlled studies that 
included POEMs published after the year 2000. Exclusion criteria included previous Cochrane 
reviews, previous student published systematic reviews, and individuals less than 12 years of 
age. All studies used similar statistics to evaluate the outcomes where p-value is considered 
statistically significant if it is less than or equal to 0.05. The demographics of the studies are 
included and outlined below in Table 1. 
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Table 1 – Demographics & Characteristics of included studies 
Study Type #Pts Age Inclusion Exclusion W/D Interventions 
Gollnick3 
(2001) 
 
 
RCT 85 15-
31 
Male patients 
with severe 
inflammatory 
acne. 
Severity of acne 
at > 4 on the 
Leeds scale. 
The face had to 
display at least 
2 deep 
inflammatory 
lesions. 
 
Women and patients 
with milder forms of 
acne. 
Patients with 
photosensitivity and/or 
allergies to treatments. 
Patients who have 
received any systemic 
treatment within 4 
weeks of study or 
topical treatment 
within 2 weeks. 
 
 
8 Isotretinoin 
cumulative 
dose of 106-
112 mg/kg, 
PO for 6 
months 
VS. 
Minocycline 
100 mg daily, 
PO for 6 
months plus 
topical azelaic 
acid cream 
applied BID. 
Oprica5 
(2007) 
RCT 52 15-
35 
Male and 
female patients, 
ages 15-35, 
with moderate 
or severe 
inflammatory 
acne vulgaris 
 
 
Patients with no 
nodules, used 
oral/topical acne 
treatments within 8 
weeks of study, used 
systemic retinoids 
within 12 months of 
study, receiving drugs 
that may interfere with 
tetracycline, pregnant 
or breastfeeding, 
psychiatric or systemic 
illness, other 
dermatological issues, 
participation in other 
clinical trials. 
13 Isotretinoin 1 
mg/kg/day in 
two divided 
doses, PO for 
6 months 
VS. 
Tetracycline 
hydrochloride 
500 mg BID 
plus topical 
adapalene 
once daily for 
6 months 
 
Tan8 
(2014) 
RCT 266 12-
35 
Male and 
female patients 
of any race, 
ages 12-35, 
with severe 
facial acne 
vulgaris. 
> 20 
papules/pustules 
and > 5 nodules 
Pregnancy 45 Isotretinoin 1 
mg/kg-1 PO 
QD for 20 
weeks. 
VS. 
Doxycycline 
200 mg PO 
QD plus 
topical agent 
for 20 weeks 
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Outcomes Measured 
 Each study measured the outcomes by counting the total number of acne lesions and the 
percentage change in either total acne lesions or specific types of acne lesions, from baseline at 
various intervals throughout the treatment period. 
Results 
 In Gollnick et al.3, 85 male patients were used to compare use of oral isotretinoin and 
minocycline combined with topical azelaic acid cream for six months. Patients were examined at 
baseline and at one month intervals for the six month duration of the treatment. At each 
examination, the examiner counted the patient’s total number of open and closed comedones, 
inflammatory papules and pustules, nodes, nodules and cysts. Since total acne lesions were not 
counted in this study, the papule and pustule counts are used for the comparison data. For the 
isotretinoin group, the p-value was < 0.05, and thus proved to be statistically superior to the 
combination minocycline treatment throughout the six month course of the study. 
Table 2. Comparison of reduction of papules/pustules at end of month 6 
Intervention % Reduction in papules/pustules P-value 
Isotretinoin 97 < 0.05 
Minocycline/AA cream 88  
 
The Oprica et al.5 study employed 52 male and female patients to compare the use of oral 
isotretinoin and tetracycline combined with topical adapalene cream. Clinical and 
microbiological assessments were performed after 2, 4 and 6 months of treatment, and 2 months 
after cessation of treatment. Patients treated with isotretinoin showed prolonged significant 
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remission compared with the other group. Different types of lesions were counted at each 
examination, but for the purpose of this study, comparison of total lesions at month six in the 
male patients is utilized, although the p-value is < 0.05 in the female comparison as well. The 
female comparison at six months showed a 91% decrease in total lesions with use of oral 
isotretinoin, compared to a 63% decrease with use of the combination tetracycline therapy. The 
male comparison of total lesions at six months showed an 87% decrease in lesions with use of 
isotretinoin compared to a 43% decrease with the tetracycline, and thus demonstrated that oral 
isotretinoin was statistically superior to the combination tetracycline treatment at the conclusion 
of the six month study. 
Table 3. Comparison of reduction of total acne lesions at end of month 6 
Intervention % Reduction of total lesions P-value 
Isotretinoin 87% < 0.05 
Tetracycline/topical agent 43%  
 
The Tan et al.8 study included 266 male and female patients to compare the use of oral 
isotretinoin with doxycycline combined with a topical agent. The participants of this study were 
examined for lesion counting at weeks: 2, 4, 8, 12, 16 and 20. For the purpose of this review, 
results are shown for the examination at week 20 when treatment is complete, and females are 
not excluded from this table, although they only comprise 39 of the 266 participants. By the end 
of the treatment course, isotretinoin again demonstrated to be statistically superior to 
doxycycline combined with a topical agent, with isotretinoin users showing a 93% reduction in 
total acne lesions compared with a 78% reduction in doxycycline users. Isotretinoin was also 
superior in reducing nodules (96% vs. 89%), and papules and pustules (95% vs. 80%). 
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Table 4. Comparison of reduction of total acne lesions at week 20 
Intervention % Reduction of total lesions P-value 
Isotretinoin 93% < 0.01 
Doxycycline/topical agent 78%  
 
All three studies demonstrated that isotretinoin is superior to antibiotic therapy in the 
reduction of acne lesions, with each study yielding a p-value less than 0.05. Using the control 
event rate (CER) and experimental event rate (EER), the relative benefit increase (RBI) was 
calculated followed by the absolute benefit increase (ABI).  ABI shows an increase in treatment 
effect with the isotretinoin group compared to the antibiotic group. The RBI represents the 
effectiveness of isotretinoin and the relative probability of experiencing clinical improvement 
with isotretinoin treatment compared to the antibiotic treatment studied in each article. The 
number needed to treat (NNT) is calculated to determine the number of patients that need to 
receive oral isotretinoin in order to benefit one patient with symptom improvement.  
Table 5. Treatment Effects 
Study P-value CER EER RBI ABI NNT 
Gollnick < 0.05 88% 97% 101% 9% 12 
Oprica < 0.05 43% 87% 100% 44% 3 
Tan < 0.01 78% 93% 19% 15% 7 
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Discussion 
Isotretinoin is widely known by the brand name Accutane, but this brand is no longer 
available in the United States. It was taken off the market in the U.S. in 2009, but alternative 
brands of Isotretinoin exist here in the U.S. Some of the brands available today include:     
Absorica, Amnesteem, Claravis, Myorisan, and Zenatane.10  
 Isotretinoin is a teratogenic medication, and is not to be taken if you are pregnant or are 
to become pregnant during the treatment course or within one month after its completion, as 
severe birth defects and miscarriage can occur.10 To avoid these adverse effects, it is strongly 
recommended for women of reproductive age to have two serum pregnancy tests obtained prior 
to starting treatment, and each month thereafter while using isotretinoin.7 It is also recommended 
that sexually active individuals use two forms of birth control during the duration of isotretinoin 
use, and it is required for men and women to register with iPledge, which is a monitoring 
program aimed at reducing exposure of the drug to pregnant individuals.7 In addition to the 
teratogenic effects, isotretinoin has been linked to other serious side effects and can lead to 
elevated liver enzymes and high triglyceride levels.7 For this reason, users are also required to 
have blood drawn every four weeks to include: complete blood cell count (CBC), cholesterol, 
triglyceride, and liver enzyme panel.7  
 In addition to use as a treatment for severe acne, isotretinoin has also been used to treat 
other conditions. For individuals with discoid lupus erythematosus, isotretinoin is considered 
effective at treating the hypertrophic lesions associated with the disease.7 Isotretinoin has also 
shown to be effective in the treatment of the erythematous facial flares associated with rosacea.7 
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 The main limitation of this study was the small study size of two of the three articles. 
Oprica et al.5 only included 52 participants, which may not be a sufficient size to make the 
conclusion that isotretinoin is superior to minocycline in treatment of severe acne. Gollnick et 
al.3 included 85 participants, which may also be considered small for this study. This article also 
excluded women from the study, and did not provide statistics for reduction of the total number 
of acne lesions, which led to the use of reduction of papules and pustules for the purposes of this 
review. Tan et al.8 included 266 participants in the study, but despite the sufficient number of 
participants, only 39 were females.  
Conclusion 
 After reviewing these three studies, evidence strongly suggests that use of oral 
isotretinoin is superior to oral antibiotic therapy in the treatment of severe acne in adults. 
Although there were flaws in the studies, primarily the small sample size and the predominance 
of males, the results were considered statistically significant in favor of oral isotretinoin in 
reducing acne lesions. Of note, oral antibiotic therapy may still be a viable alternative to 
isotretinoin in treatment of severe acne for some people, and these antibiotics will generally 
cause fewer harmful side effects than isotretinoin.  Future studies are warranted that include a 
greater number of participants, specifically of the female gender.  
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